StockGlow

Bristol-Myers Squibb Company (BMY)

$61.51+0.01%
Market signal
77
Leaning Bullish
BearishBullish

The outlook

Bristol-Myers Squibb is trading near the top of its 52-week range, with analysts collectively leaning toward a buy rating. The stock sits above both its 50- and 200-day moving averages, though the average analyst price target sits roughly 2% below the current level.

What's behind the signal

Analyst consensusBuy — 2.5 avg of 24 analysts
Price trendAbove its 50- & 200-day averages
52-week range93% of the way from its 52-week low to high
Price targetAvg target +2% vs current price
Market cap
$125.61B
52-wk high
$62.89
52-wk low
$42.52
50-day avg
$57.34
200-day avg
$54.99
Trailing P/E
17.0

The “market signal” is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works